| Net income | |
| Depreciation and amortization | 3.43M |
| Provision for doubtful accounts, product returns, and inventory valuation | |
| Non-cash stock compensation expense | 1.71M |
| Deferred taxes | 1.15M |
| Gain on sale of assets held for sale | |
| Other | 461K |
| Changes in operating assets | -1.54M |
| Changes in operating liabilities | -32.35M |
| Net cash provided by operating activities | -20.58M |
| Purchases of property and equipment | |
| Proceeds from sale of assets held for sale | |
| Proceeds from repayment of loan | |
| Other | |
| Net cash provided (used) in investing activities | -5.78M |
| Proceeds from exercise of stock options and issuance of common stock | 2.23M |
| Net cash provided by financing activities | 2.23M |
| Effect of exchange rate changes on cash and cash equivalents | 285K |
| Net increase in cash and cash equivalents | -23.85M |
| Cash and cash equivalents, beginning of period | 214.85M |
| Cash and cash equivalents, end of period | 191M |